MedTrace Logo

The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle Diseases

NCT05726695 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-02-14

No results posted yet for this study

Summary

The aim of the study is to determine the analytical characteristics of the microRNA enzymatic immunoassay (miREIA) method and to determine various relations among miRNA biomarkers and heart failure (HF) with reduced ejection fraction(HFrEF).

The investigators assume that there are correlations between levels of selected miRNA and HFrEF. These correlations provide information to formulate pathophysiological conclusions, which will significantly contribute to early diagnostics and also the treatment of this disease.

Conditions

Interventions

DIAGNOSTIC_TEST

microRNA test

Laboratory analysis for the detection of microRNA in blood samples.

DIAGNOSTIC_TEST

Heart ultrasound examination

Heart ultrasound examination will be performed as a standard cardiology examination.

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Lukáš Evin, MD,Ph.D. · University Hospital Ostrava

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • Czechia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05726695 on ClinicalTrials.gov